-
-
Call more information
660-596-2224 -
While death and abuse rates from prescription opioids are dropping, death rates from heroin use are going in the opposite direction. Behind every apparent bit of progress in healthcare lurks disaster. First the progress, which is indeed good news: drug diversion and abuse of prescription opioids, which saw a horrifying increase over the last decade, […]
Read MoreThe clock is ticking toward April 1, when the latest sustainable growth rate (SGR) fix expires and physicians are due to get a 21% cut in Medicare payments. Some members of Congress are trying to eliminate the SGR payment methodology once again. In late January 2015, a House subcommittee held hearings on how to build […]
Read MoreThe prevalence of fibromyalgia varied by as much as fourfold, depending on which of three different American College of Rheumatology diagnostic criteria sets was used, a new study reveals. The findings were published online January 28 in Arthritis & Rheumatology by Gareth T. Jones, PhD, from the University of Aberdeen, United Kingdom, and colleagues. The […]
Read MorePublished in The Journal of the American Society of Anesthesiologists on 1 2015. Authors: Mark C. Wesley, M.D. et al Background: Tranexamic acid (TXA) is one of the most commonly used antifibrinolytic medications in children undergoing repair of congenital heart defects. However, a pharmacokinetics analysis of TXA has never been performed in neonates or young […]
Read MorePublished in Neurology 2015 Jan 13; 84:159 Authors: Roberts JI et al. A large national survey in Canada reveals insights into neurologist-related barriers to referral for possible surgical treatment of drug-resistant seizure disorders. Marked underuse of resective surgery for drug-resistant focal epilepsy has not changed in recent decades. Although substantial accumulated evidence has demonstrated safety […]
Read More